Briefing Summary: US FDA Posts Advisory Committee Materials about the Data Requirements for Food and Airborne Allergy Immunotherapies – JAN 21, 2016 (APAC)

The US FDA has posted Briefing Materials for the Thursday, January 21, 2016 meeting of the Allergenic Products Advisory Committee (APAC). The Committee will discuss safety and effectiveness data, including challenge study endpoints, for licensure of food allergy immunotherapy products, and the clinical development of aeroallergen (airborne) immunotherapy products for the prevention of respiratory allergic disease.

See the SAC Tracker report